373 related articles for article (PubMed ID: 18096175)
1. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies.
Gika HG; Theodoridis GA; Wilson ID
J Chromatogr A; 2008 May; 1189(1-2):314-22. PubMed ID: 18096175
[TBL] [Abstract][Full Text] [Related]
2. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine.
Gika HG; Theodoridis GA; Wingate JE; Wilson ID
J Proteome Res; 2007 Aug; 6(8):3291-303. PubMed ID: 17625818
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples.
Gika HG; Macpherson E; Theodoridis GA; Wilson ID
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):299-305. PubMed ID: 18579458
[TBL] [Abstract][Full Text] [Related]
4. Mercapturic acids of styrene in man: comparability of the results obtained by LC/MS/MS and by HPLC-fluorimeter, and stability of samples under different storage conditions.
Negri S; Maestri L; Andreoli R; Manini P; Mutti A; Imbriani M
Toxicol Lett; 2006 Apr; 162(2-3):225-33. PubMed ID: 16242871
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
Prasad B; Singh S
J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
[TBL] [Abstract][Full Text] [Related]
6. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Huang W; Moody DE; McCance-Katz EF
Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
[TBL] [Abstract][Full Text] [Related]
7. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
[TBL] [Abstract][Full Text] [Related]
8. High temperature-ultra performance liquid chromatography-mass spectrometry for the metabonomic analysis of Zucker rat urine.
Gika HG; Theodoridis G; Extance J; Edge AM; Wilson ID
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):279-87. PubMed ID: 18485837
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent Gadocoletate ion in human plasma, urine and faeces.
Setti I; Celeste R; Mariani G; Dal Fiume D; Morisetti A; Lorusso V
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):1-15. PubMed ID: 16574506
[TBL] [Abstract][Full Text] [Related]
10. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
11. Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study.
Bhaumik U; Ghosh A; Sarkar AK; Bose A; Selvan PS; Sengupta P; Chakraborty US; Ghosh D; Pal TK
J Pharm Biomed Anal; 2008 Dec; 48(5):1404-10. PubMed ID: 18986788
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of equine urine reactivity towards phase II metabolites of 17-hydroxy steroids by liquid chromatography/tandem mass spectrometry.
Fidani M; Gamberini MC; Pasello E; Palazzoli F; De Iuliis P; Montana M; Arioli F
Rapid Commun Mass Spectrom; 2009 Jan; 23(1):65-76. PubMed ID: 19051232
[TBL] [Abstract][Full Text] [Related]
13. Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine.
Gika HG; Theodoridis GA; Wilson ID
J Sep Sci; 2008 May; 31(9):1598-608. PubMed ID: 18461568
[TBL] [Abstract][Full Text] [Related]
14. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
[TBL] [Abstract][Full Text] [Related]
15. Analysis of alkaloids in Coptis chinensis Franch by accelerated solvent extraction combined with ultra performance liquid chromatographic analysis with photodiode array and tandem mass spectrometry detections.
Chen J; Wang F; Liu J; Lee FS; Wang X; Yang H
Anal Chim Acta; 2008 Apr; 613(2):184-95. PubMed ID: 18395058
[TBL] [Abstract][Full Text] [Related]
16. An approach to enhancing coverage of the urinary metabonome using liquid chromatography-ion mobility-mass spectrometry.
Harry EL; Weston DJ; Bristow AW; Wilson ID; Creaser CS
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):357-61. PubMed ID: 18502703
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry.
Idborg H; Zamani L; Edlund PO; Schuppe-Koistinen I; Jacobsson SP
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):9-13. PubMed ID: 16181815
[TBL] [Abstract][Full Text] [Related]
18. Comparative urine analysis by liquid chromatography-mass spectrometry and multivariate statistics: method development, evaluation, and application to proteinuria.
Kemperman RF; Horvatovich PL; Hoekman B; Reijmers TH; Muskiet FA; Bischoff R
J Proteome Res; 2007 Jan; 6(1):194-206. PubMed ID: 17203964
[TBL] [Abstract][Full Text] [Related]
19. Stability studies of testosterone and epitestosterone glucuronides in urine.
Jiménez C; de la Torre R; Segura J; Ventura R
Rapid Commun Mass Spectrom; 2006; 20(5):858-64. PubMed ID: 16470578
[TBL] [Abstract][Full Text] [Related]
20. Stability experiments in human urine with EO9 (apaziquone): a novel anticancer agent for the intravesical treatment of bladder cancer.
Vainchtein LD; Rosing H; Mirejovsky D; Lenaz L; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2007 Jan; 43(1):285-92. PubMed ID: 16920321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
